@article{df01f2d1dcc2408e9fa96bb5b0d8f4a2,
title = "Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis",
abstract = "Alcohol consumption is thought to be one of the modifiable risk factors for colorectal cancer (CRC). However, the causality and mechanisms by which alcohol exerts its carcinogenic effect are unclear. We evaluated the association between alcohol consumption and CRC risk by analyzing data from 32 cohort studies and conducted two-sample Mendelian randomization (MR) analysis to examine for casual relationship. To explore the effect of alcohol related DNA methylation on CRC risk, we performed an epigenetic MR analysis with data from an epigenome-wide association study (EWAS). We additionally performed gene-alcohol interaction analysis nested in the UK Biobank to assess effect modification between alcohol consumption and susceptibility genes. We discovered distinct effects of alcohol on CRC incidence and mortality from the meta-analyses, and genetic predisposition to alcohol drinking was causally associated with an increased CRC risk (OR = 1.79, 95% CI: 1.23-2.61) using two-sample MR approaches. In epigenetic MR analysis, two alcohol-related CpG sites (cg05593667 and cg10045354 mapped to COLCA1/COLCA2 gene) were identified causally associated with an increased CRC risk (P < 8.20 × 10-4 ). Gene-alcohol interaction analysis revealed that carriage of the risk allele of the eQTL (rs3087967) and mQTL (rs11213823) polymorphism of COLCA1/COLCA2 would interact with alcohol consumption to increase CRC risk (PInteraction = .027 and PInteraction = .016). Our study provides comprehensive evidence to elucidate the role of alcohol in CRC and highlights that the pathogenic effect of alcohol on CRC could be partly attributed to DNA methylation by regulating the expression of COLCA1/COLCA2 gene.",
keywords = "Alcohol Drinking/epidemiology, Cohort Studies, Colorectal Neoplasms/epidemiology, DNA Methylation, Genome-Wide Association Study, Humans, Mendelian Randomization Analysis/methods, Neoplasm Proteins/genetics, Polymorphism, Single Nucleotide",
author = "Xuan Zhou and Lijuan Wang and Jiarui Xiao and Jing Sun and Lili Yu and Han Zhang and Xiangrui Meng and Shuai Yuan and Maria Timofeeva and Law, {Philip J} and Houlston, {Richard S} and Kefeng Ding and Dunlop, {Malcolm G} and Evropi Theodoratou and Xue Li",
note = "Funding Information: Our study was conducted using CRC summary statistics form 12 previous CRC GWASs and individual data from the UK Biobank (application number 66345). The authors thank all the participants, institutions and their staff for providing data. Xue Li is supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001). Evropi Theodoratou is supported by a CRUK Career Development Fellowship (C31250/A22804). The work is supported by Programme Grant funding from Cancer Research UK (C348/A12076) and by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre. This work is also funded by a grant to Malcolm G. Dunlop as Project Leader with the MRC Human Genetics Unit Centre Grant (U127527198). Funding Information: Our study was conducted using CRC summary statistics form 12 previous CRC GWASs and individual data from the UK Biobank (application number 66345). The authors thank all the participants, institutions and their staff for providing data. Xue Li is supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001). Evropi Theodoratou is supported by a CRUK Career Development Fellowship (C31250/A22804). The work is supported by Programme Grant funding from Cancer Research UK (C348/A12076) and by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre. This work is also funded by a grant to Malcolm G. Dunlop as Project Leader with the MRC Human Genetics Unit Centre Grant (U127527198). Funding Information: CRUK Career Development Fellowship, Grant/Award Number: C31250/A22804; Natural Science Fund for Distinguished Young Scholars of Zhejiang Province, Grant/Award Number: LR22H260001; Project Leader with the MRC Human Genetics Unit Centre Grant, Grant/Award Number: U127527198; Edinburgh CRUK Cancer Research Centre; Programme Grant funding from Cancer Research UK, Grant/Award Number: C348/A12076 Funding information Publisher Copyright: {\textcopyright} 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.",
year = "2022",
month = jul,
day = "1",
doi = "10.1002/ijc.33945",
language = "English",
volume = "151",
pages = "83--94",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",
}